Information Journal Paper
APA:
Copy. (2018). Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy. JOURNAL OF NANOBIOTECHNOLOGY, 16(1), 0-0. SID. https://sid.ir/paper/772884/en
Vancouver:
Copy. Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy. JOURNAL OF NANOBIOTECHNOLOGY[Internet]. 2018;16(1):0-0. Available from: https://sid.ir/paper/772884/en
IEEE:
Copy, “Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy,” JOURNAL OF NANOBIOTECHNOLOGY, vol. 16, no. 1, pp. 0–0, 2018, [Online]. Available: https://sid.ir/paper/772884/en